Related Experiment Videos
Reactogenecity of indigenously produced measles vaccine
I Bhargava1, B C Chhaparwal, M A Phadke
1Serum Institute of India Research Foundation, Pune.
Indian Pediatrics
|October 1, 1996
Summary
The indigenously produced measles vaccine from EZ strain is safe and well-tolerated in children. Mild side effects were observed, with neurological events being rare and without sequelae.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Measles vaccination is crucial for public health.
- Assessing the safety and reactogenicity of new vaccine strains is essential.
Purpose of the Study:
- To evaluate the safety and reactogenicity of an indigenously produced measles vaccine derived from the EZ strain.
- To compare its safety profile with existing vaccines.
Main Methods:
- A longitudinal clinical follow-up study was conducted.
- 12,470 children aged 9-15 months received the EZ strain measles vaccine.
- Clinical and neurological examinations were performed at multiple time points post-vaccination.
Main Results:
- 31% of children experienced mild side effects, predominantly within the first two weeks.
- Common side effects included coryza, fever, cough, and diarrhea.
- Only two cases of convulsions with no sequelae were reported.
Conclusions:
- The Indian-manufactured measles vaccine using the EZ strain is safe.
- Its reactogenicity, including neurological aspects, is lower than the Schwarz strain vaccine previously reported in India.